SDGR

New Analyst Forecast: $SDGR Given 'Overweight' Rating

We just received data on a new analyst forecast for $SDGR. KeyBanc gave a rating of 'Overweight' for $SDGR.

$SDGR Analyst Ratings

Wall Street analysts have issued reports on $SDGR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • KeyBanc issued a "Overweight" rating on 04/16/2025
  • BMO Capital issued a "Outperform" rating on 11/13/2024

To track analyst ratings and price targets for $SDGR, check out Quiver Quantitative's $SDGR forecast page.

$SDGR Insider Trading Activity

$SDGR insiders have traded $SDGR stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $SDGR stock by insiders over the last 6 months:

  • KAREN AKINSANYA (President of R&D, Therapeutics) has made 0 purchases and 3 sales selling 16,723 shares for an estimated $419,570.
  • YVONNE TRAN (EVP, CLO & CPO) has made 0 purchases and 2 sales selling 4,730 shares for an estimated $129,484.
  • GEOFFREY CRAIG PORGES (EVP & CFO) sold 5,491 shares for an estimated $119,484
  • JENNY HERMAN (SVP & Controller) has made 0 purchases and 2 sales selling 1,525 shares for an estimated $35,044.
  • ROBERT LORNE ABEL (See Remarks) sold 1,225 shares for an estimated $31,837
  • KENNETH PATRICK LORTON (EVP, CTO & COO, Software) sold 985 shares for an estimated $24,063

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$SDGR Hedge Fund Activity

We have seen 95 institutional investors add shares of $SDGR stock to their portfolio, and 99 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.


This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.